IL-PROJECT44
4.3.2020 13:02:09 CET | Business Wire | Press release
According to Gartner Inc.’s recently released Market Guide for Real-Time Transportation Visibility Platforms , visibility is only possible with comprehensive network coverage and compliance. Today project44, the global leader in advanced visibility for shippers and logistics service providers, announced a new service level agreement (SLA) around full truckload carrier onboarding. This groundbreaking agreement demonstrates the technology provider’s commitment to results and offers a money-back guarantee.
Under the new carrier coverage SLA, project44 will guarantee that 90% of a shipper’s contracted truckload carriers in North America and Europe will be live within 30 days of starting implementation. With carrier compliance at the foundation of transportation visibility, this commitment will rapidly deliver upon the promise of real-time visibility and provide project44 customers a significant competitive advantage in today’s Delivery Economy.
“Carrier network coverage is the linchpin to visibility. Uline evaluated a variety of technology providers and knew that our full truckload visibility implementation would fail without adequate network coverage. It was very clear to us that p44 provided the largest carrier network along with the most scalable and automated onboarding process,” said Angelo Ventrone, VP of Logistics at Uline, the leading distributor of shipping, industrial and packaging materials in North America. “As a partner, they went above and beyond to ensure compliance, which has resulted in truckload tracking percentages of over 95%. Ultimately selecting project44 has enabled Uline to efficiently deliver on a differentiated customer experience.”
While this service level agreement is new to the industry, project44’s commitment to its carrier network is not. The visibility provider serves over 300 enterprise customers with the largest carrier network across North America and Europe. This includes connections to more than 760 ELD/telematics providers over more than 48 countries, and connections to 4.33 million drivers, 3.55 million trucks, and 800,000 fleets. Thanks to its automated onboarding application, the Network Management Center™, project44 enables customers to accelerate their time to value and immediately see the results of their visibility investment.
“Coop operates with more than 1,000 stores who all need deliveries on a weekly basis. For us to have the most efficient supply chain, we lacked an end-to-end overview of our carrier and subcontractor deliveries,” said Kennet Thorsen, Senior Distribution Manager at Coop Denmark A/S. “Our organization leveraged project44’s robust carrier network and world-class onboarding process to rapidly increase the ROI of our technology investment, streamline operations and better meet service goals towards our stores.”
project44's Network Management Center debuted in Europe over three years ago, driving unprecedented time-to-live with Truckload carriers. 48% of carriers achieve live status within one day, 81% within ten days – all through an automated, self-service cloud-based application. By combining project44’s automated tools and enterprise-grade implementation processes, the world’s leading ecommerce retailer, utilizing more than 2,500 different truckload providers across Europe, saw 95% connectivity in the first 45 days of working with project44. The commitment outlined in this SLA provides shippers of all sizes with the tools necessary to compete with even the largest ecommerce companies.
“Carrier coverage is critical to seeing the ROI of visibility, and project44 is dedicated to quickly achieving high compliance percentages for our customers. It has been our goal from day one to build global and multimodal connectivity and serve as the supply chain ecosystem’s connective tissue. This SLA formalizes our commitment, ensuring the entire industry truly understands the power the right visibility solution can have on delivering rapid and enduring results for the world’s leading retailers, manufacturers and distributors,” stated Tommy Barnes, Head of Global Network Partnerships at project44.
By following project44’s implementation program and best practices, project44 will offer the 30-day onboarding SLA with a money back guarantee to shippers in North America and Europe. To learn more about the SLA and project44’s Advanced Visibility Platform™, contact the project44 team today .
About project44
project44 is the world’s only advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean. To learn more, visit www.project44.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200304005098/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
